NCT00000461View on ClinicalTrials.gov

Harvard Atherosclerosis Reversibility Project (HARP)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1986

Study Completion Date

November 30, 1992

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia

Interventions

DRUG

pravastatin

DRUG

niacin

DRUG

cholestyramine

DRUG

gemfibrozil

DRUG

fatty acids, omega-3

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH